MD and Karen Honey PhD during Meet the Editors-in-Chief of Cancer Immunology Research: Robert D. Schreiber

Name: High-Throughput Serum Proteomics of 1000+ Checkpoint Inhibitor Patients: Insights From nELISA™ Profiling of RADIOHEAD Cohort
Start: 2025-04-29T12:30:00-05:00
End: 2025-04-29T13:30:00-05:00

Upcoming Featured Industry Events